Trainingsinduzierte Hypoalgesie im Ausdauersport

Menschen nehmen Schmerz sehr unterschiedlich wahr. Interessanterweise scheinen diejenigen, die Ausdauersport betreiben, über ein effizienteres Schmerzmodulationssystem zu verfügen als Nichtsportler*innen. Könnte Ausdauersport demnach einer Chronifizierung von Schmerzen entgegenwirken?

Publication History

Article published online:
22 May 2023

• Literatur

• 1 Treede RD, Rief W, Barke A. et al. Chronic pain as a symptom or a disease: the IASP Classification of Chronic Pain for the International Classification of Diseases (ICD-11). Pain 2019; 160: 19-27 DOI: 10.1097/j.pain.0000000000001384.
• 2 Kröner-Herwig B. Schmerz als biopsychosoziales Phänomen – eine Einführung. In: Kröner-Herwig B, Frettlöh J, Klinger R, Nilges P, Hrsg. Schmerzpsychotherapie: Grundlagen – Diagnostik – Krankheitsbilder – Behandlung. Berlin, Heidelberg: Springer; 2017. DOI: 10.1007/978-3-662-50512-0_1
• 3 Lang E, Eisele R, Jankowsky H. et al. Ergebnisqualität in der ambulanten Versorgung von Patienten mit chronischen Rückenschmerzen. Der Schmerz 2000; 14: 146-159 DOI: 10.1007/s004820070040.
• 4 Tarnanen S, Luomajoki H. Trainingsinduzierte Hypoalgesie: Mit Bewegung gegen den Schmerz. SchmerzTherapie 2022; 5: 64-69 DOI: 10.1055/a-1756-8779.
• 5 Tesarz J, Schuster AK, Hartmann M. et al. Pain perception in athletes compared to normally active controls: A systematic review with meta-analysis. Pain 2012; 153: 1253-1262 DOI: 10.1016/j.pain.2012.03.005.
• 6 Flood A, Waddington G, Cathcart S. Examining the relationship between endogenous pain modulation capacity and endurance exercise performance. Res Sports Med 2017; 25: 300-312 DOI: 10.1080/15438627.2017.1314291.
• 7 Geisler M, Weiß T. Schmerzmodulation durch Ausdauersport. Manuelle Medizin 2022; 60: 143-150 DOI: 10.1007/s00337-022-00866-2.
• 8 Schaible H-G, Weiss T. Physiologie des Schmerzes und der Nozizeption. In: van den Berg F, Hrsg. Angewandte Physiologie: Band 4: Schmerzen verstehen und beeinflussen. 2. Aufl. Stuttgart: Georg Thieme Verlag; 2008
• 9 Tracey I, Mantyh PW. The cerebral signature for pain perception and its modulation. Neuron 2007; 55: 377-391 DOI: 10.1016/j.neuron.2007.07.012.
• 10 Basbaum AI, Fields HL. Endogenous pain control mechanisms: review and hypothesis. Ann Neurol 1978; 4: 451-462 DOI: 10.1002/ana.410040511.
• 11 Yilmaz P, Diers M, Diener S. et al. Brain correlates of stress-induced analgesia. Pain 2010; 151: 522-529 DOI: 10.1016/j.pain.2010.08.016.
• 12 Koltyn KF. Analgesia following exercise: a review. Sports Med 2000; 29: 85-98 DOI: 10.2165/00007256-200029020-00002.
• 13 Amanzio M, Benedetti F. Neuropharmacological dissection of placebo analgesia: expectation-activated opioid systems versus conditioning-activated specific subsystems. J Neurosci 1999; 19: 484-494 DOI: 10.1523/JNEUROSCI.19-01-00484.1999.
• 14 Roa Romero Y, Straube T, Nitsch A. et al. Interaction between stimulus intensity and perceptual load in the attentional control of pain. Pain 2013; 154: 135-140 DOI: 10.1016/j.pain.2012.10.003.
• 15 Yarnitsky D, Arendt-Nielsen L, Bouhassira D. et al. Recommendations on terminology and practice of psychophysical DNIC testing. Eur J Pain 2010; 14: 339 DOI: 10.1016/j.ejpain.2010.02.004.
• 16 Damien J, Colloca L, Bellei-Rodriguez CE. et al. Pain Modulation: From Conditioned Pain Modulation to Placebo and Nocebo Effects in Experimental and Clinical Pain. Int Rev Neurobiol 2018; 139: 255-296 DOI: 10.1016/bs.irn.2018.07.024.
• 17 Yarnitsky D, Bouhassira D, Drewes AM. et al. Recommendations on practice of conditioned pain modulation (CPM) testing. Eur J Pain 2015; 19: 805-806 DOI: 10.1002/ejp.605.
• 18 McPhee ME, Vaegter HB, Graven-Nielsen T. Alterations in pronociceptive and antinociceptive mechanisms in patients with low back pain: a systematic review with meta-analysis. Pain 2020; 161: 464-475 DOI: 10.1097/j.pain.0000000000001737.
• 19 Lewis GN, Rice DA, McNair PJ. Conditioned Pain Modulation in Populations With Chronic Pain: A Systematic Review and Meta-Analysis. J Pain 2012; 13: 936-944 DOI: 10.1016/j.jpain.2012.07.005.
• 20 Bingel U. Mechanisms of endogenous pain modulation illustrated by placebo analgesia: functional imaging findings. Schmerz 2010; 24: 122-129 DOI: 10.1007/s00482-010-0901-7.
• 21 Wager TD, Atlas LY. The neuroscience of placebo effects: connecting context, learning and health. Nat Rev Neurosci 2015; 16: 403-418 DOI: 10.1038/nrn3976.
• 22 Black J, Chesher GB, Starmer GA. et al. The painlessness of the long distance runner. Med J Aust 1979; 1: 522-523 DOI: 10.5694/j.1326-5377.1979.tb119352.x.
• 23 Naugle KM, Fillingim RB, Riley JL. A meta-analytic review of the hypoalgesic effects of exercise. J Pain 2012; 13: 1139-1150 DOI: 10.1016/j.jpain.2012.09.006.
• 24 Koltyn KF. Exercise-Induced Hypoalgesia and Intensity of Exercise. Sports Med 2002; 32: 477-487 DOI: 10.2165/00007256-200232080-00001.
• 25 Hoffman MD, Hoffman DR. Does aerobic exercise improve pain perception and mood? A review of the evidence related to healthy and chronic pain subjects. Curr Pain Headache Rep 2007; 11: 93-97 DOI: 10.1007/s11916-007-0004-z.
• 26 Janal MN, Colt EW, Clark WC. et al. Pain sensitivity, mood and plasma endocrine levels in man following long-distance running: effects of naloxone. Pain 1984; 19: 13-25 DOI: 10.1016/0304-3959(84)90061-7.
• 27 Goldfarb AH, Jamurtas AZ. Beta-endorphin response to exercise. An update. Sports Med 1997; 24: 8-16 DOI: 10.2165/00007256-199724010-00002.
• 28 Dearman J, Francis KT. Plasma levels of catecholamines, cortisol, and beta-endorphins in male athletes after running 26.2, 6, and 2 miles. J Sports Med Phys Fitness 1983; 23: 30-38
• 29 Boecker H, Sprenger T, Spilker ME. et al. The runner's high: opioidergic mechanisms in the human brain. Cereb Cortex 2008; 18: 2523-2531 DOI: 10.1093/cercor/bhn013.
• 30 Scheef L, Jankowski J, Daamen M. et al. An fMRI study on the acute effects of exercise on pain processing in trained athletes. Pain 2012; 153: 1702-1714 DOI: 10.1016/j.pain.2012.05.008.
• 31 Geisler M, Eichelkraut L, Miltner WHR. et al. Expectation of exercise in trained athletes results in a reduction of central processing to nociceptive stimulation. Behav Brain Res 2019; 356: 314-321 DOI: 10.1016/j.bbr.2018.08.036.
• 32 Geisler M, Eichelkraut L, Miltner WHR. et al. An fMRI study on runner’s high and exercise-induced hypoalgesia after a 2-h-run in trained non-elite male athletes. Sport Sci Health 2020; 16: 159-167 DOI: 10.1007/s11332-019-00592-8.
• 33 Fuss J, Gass P. Endocannabinoids and voluntary activity in mice: runner's high and long-term consequences in emotional behaviors. Exp Neurol 2010; 224: 103-105 DOI: 10.1016/j.expneurol.2010.03.016.
• 34 Fuss J, Steinle J, Bindila L. et al. A runner’s high depends on cannabinoid receptors in mice. PNAS 2015; 112: 13105-13108 DOI: 10.1073/pnas.1514996112.
• 35 Geva N, Defrin R. Enhanced pain modulation among triathletes: a possible explanation for their exceptional capabilities. Pain 2013; 154: 2317-2323 DOI: 10.1016/j.pain.2013.06.031.
• 36 Johnson MH, Stewart J, Humphries SA. et al. Marathon runnersʼ reaction to potassium iontophoretic experimental pain: pain tolerance, pain threshold, coping and self-efficacy. Eur J Pain 2012; 16: 767-774 DOI: 10.1002/j.1532-2149.2011.00059.x.
• 37 Freund W, Weber F, Billich C. et al. Ultra-marathon runners are different: investigations into pain tolerance and personality traits of participants of the TransEurope FootRace 2009. Pain Pract 2013; 13: 524-532 DOI: 10.1111/papr.12039.
• 38 Pettersen SD, Aslaksen PM, Pettersen SA. Pain Processing in Elite and High-Level Athletes Compared to Non-athletes. Front Psychol 2020; 11: 1908 DOI: 10.3389/fpsyg.2020.01908.
• 39 Flood A, Waddington G, Thompson K. et al. Increased conditioned pain modulation in athletes. J Sports Sci 2017; 35: 1066-1072 DOI: 10.1080/02640414.2016.1210196.
• 40 Geisler M, Ritter A, Herbsleb M. et al. Neural mechanisms of pain processing differ between endurance athletes and nonathletes: A functional connectivity magnetic resonance imaging study. Hum Brain Mapp 2021; DOI: 10.1002/hbm.25659.
• 41 Geisler M, Herbsleb M, Bär K-J. et al. Dissociation of Endogenous Pain Inhibition Due to Conditioned Pain Modulation and Placebo in Male Athletes Versus Nonathletes. Front Psychol 2020; 11: 553530 DOI: 10.3389/fpsyg.2020.553530.
• 42 McDougall J, Jutzeler CR, Scott A. et al. Conditioned pain modulation in elite athletes: a systematic review and meta-analysis. Scand J Pain 2020; 20: 429-438 DOI: 10.1515/sjpain-2019-0153.
• 43 Wager TD, Rilling JK, Smith EE. et al. Placebo-induced changes in FMRI in the anticipation and experience of pain. Science 2004; 303: 1162-1167 DOI: 10.1126/science.1093065.
• 44 Grahl A, Onat S, Buchel C. The periaqueductal gray and Bayesian integration in placebo analgesia. eLife 2018; 7: e32930 DOI: 10.7554/eLife.32930.
• 45 Stein N, Sprenger C, Scholz J. et al. White matter integrity of the descending pain modulatory system is associated with interindividual differences in placebo analgesia. Pain 2012; 153: 2210-2217 DOI: 10.1016/j.pain.2012.07.010.
• 46 Eippert F, Bingel U, Schoell ED. et al. Activation of the opioidergic descending pain control system underlies placebo analgesia. Neuron 2009; 63: 533-543 DOI: 10.1016/j.neuron.2009.07.014.
• 47 Alfredson H, Pietilä T, Jonsson P. et al. Heavy-Load Eccentric Calf Muscle Training For e Treatment of Chronic Achilles Tendinosis. Am J Sports Med 1998; 26: 360-366 DOI: 10.1177/03635465980260030301.
• 48 Silbernagel KG, Thomeé R, Eriksson BI. et al. Continued sports activity, using a pain-monitoring model, during rehabilitation in patients with Achilles tendinopathy: a randomized controlled study. Am J Sports Med 2007; 35: 897-906 DOI: 10.1177/0363546506298279.